olprinone and Asthma

olprinone has been researched along with Asthma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimura, M; Hashimoto, T; Hirose, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Tachibana, H; Watanabe, K1
Fujimura, M; Hashimoto, T; Hirose, T; Ishiura, Y; Kamio, Y; Matsuda, T; Myou, S; Tachibana, H1
Fujimura, M; Hirose, T; Kurashima, K; Myou, S; Nakao, S; Tachibana, H1
Hashimoto, H; Hirota, K; Ishihara, H; Kabara, S; Matsuki, A1

Trials

1 trial(s) available for olprinone and Asthma

ArticleYear
Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients.
    American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:3

    Topics: Administration, Inhalation; Adult; Aged; Albuterol; Analysis of Variance; Asthma; Bronchodilator Agents; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pyridones; Vital Capacity

1999

Other Studies

3 other study(ies) available for olprinone and Asthma

ArticleYear
Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients.
    British journal of clinical pharmacology, 2003, Volume: 55, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aminophylline; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Drug Combinations; Female; Forced Expiratory Volume; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pyridones; Vital Capacity

2003
Effect of aerosolized administration of KF19514, a phosphodiesterase 4 inhibitor, on bronchial hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea-pigs.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2000, Volume: 30, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Aerosols; Animals; Antigens; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Imidazoles; Male; Methacholine Chloride; Naphthyridines; Ovalbumin; Phosphodiesterase Inhibitors; Pyridones

2000
Use of olprinone, a phosphodiesterase III inhibitor, in an asthmatic patient.
    Acta anaesthesiologica Scandinavica, 2001, Volume: 45, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Airway Resistance; Anti-Asthmatic Agents; Asthma; Bronchoscopy; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Imidazoles; Intraoperative Period; Lung Compliance; Male; Phosphodiesterase Inhibitors; Pyridones

2001